Punjab Chemicals Q1FY27 Revenue Up 9% to ₹347 Cr; PAT Grows 7% to ₹22 Cr
Punjab Chemicals & Crop Protection Ltd reported Q1FY27 revenue of ₹347 Cr, up 9% YoY, driven by exports. PAT grew 7% to ₹22 Cr. EBITDA increased 18.8% to ₹41 Cr with margins at 11.8%. New products contributed 14% of revenue, growing 40% YoY. Capacity enhancement for new intermediates commercialized.
The results show healthy growth and strategic progress, which is positive for investors. However, the impact is moderated as it's a quarterly update and doesn't involve a major corporate action or a significant financial event like a merger or acquisition.
The company reported positive year-on-year growth in revenue, EBITDA, and PAT, along with improved margins. Strategic initiatives like new product commercialization and partnerships are progressing well.
Punjab Chemicals & Crop Protection Limited (PCCPL) has announced its financial results for the first quarter of FY27, reporting a revenue of ₹347 crore, marking a 9% year-on-year increase. This growth was primarily driven by an improvement in export sales, with new products contributing 14% to the revenue and growing by 40% YoY.
The company's gross margins stood at 36.6% for the quarter, an increase of 355 basis points YoY, attributed to a favorable product mix, efficiency gains, and price increases. EBITDA for Q1FY27 reached ₹41 crore, an 18.8% YoY growth, with a margin of 11.8%, bolstered by operational efficiencies and a refined product portfolio.
Profit After Tax (PAT) for the quarter was ₹22 crore, reflecting a 7% YoY growth, with PAT margins at 6.4%. The company also highlighted progress in its strategic initiatives, including the successful commercialization of capacity enhancement for new agro-intermediate products, expecting 100% volume growth in the current financial year. Commercial supply for two out of three MoU products under strategic partnerships has begun, with volume pickup anticipated from Q4FY27 onwards. Furthermore, PCCPL plans to launch two intermediate herbicide products in the domestic market in Q3/Q4FY27.
The investor presentation also provided a historical overview, detailing the company's establishment in 1975 and its evolution into a key player in Agrochemicals, Specialty Chemicals, and Pharmaceuticals. The company emphasizes a value-centric business model built on niche products and long-term partnerships, with a strategy focused on product diversification, margin expansion through backward integration and new product additions, and strengthening its CDMO portfolio.
What to do with a filing like this
Punjab Chemicals & Crop Protection Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Punjab Chemicals & Crop Protection Limited. Read the original for the full detail.